[English] 日本語
Yorodumi- EMDB-23899: SARS-CoV-2 Spike RBD in complex with neutralizing Fab SARS2-38 (l... -
+
Open data
-
Basic information
| Entry | Database: EMDB / ID: EMD-23899 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | SARS-CoV-2 Spike RBD in complex with neutralizing Fab SARS2-38 (local refinement) | |||||||||
Map data | Focused map of SARS2-38 antibody Fv bound to SARS-CoV-2 receptor binding domain | |||||||||
Sample |
| |||||||||
Keywords | Glycoprotein / Antibody / VIRAL PROTEIN-IMMUNE SYSTEM complex / Structural Genomics / Center for Structural Genomics of Infectious Diseases / CSGID | |||||||||
| Function / homology | Function and homology informationsymbiont-mediated disruption of host tissue / Maturation of spike protein / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / viral translation / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion ...symbiont-mediated disruption of host tissue / Maturation of spike protein / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / viral translation / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion / entry receptor-mediated virion attachment to host cell / membrane fusion / Attachment and Entry / host cell endoplasmic reticulum-Golgi intermediate compartment membrane / positive regulation of viral entry into host cell / receptor-mediated virion attachment to host cell / host cell surface receptor binding / symbiont-mediated suppression of host innate immune response / receptor ligand activity / endocytosis involved in viral entry into host cell / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / symbiont entry into host cell / virion attachment to host cell / SARS-CoV-2 activates/modulates innate and adaptive immune responses / host cell plasma membrane / virion membrane / identical protein binding / membrane / plasma membrane Similarity search - Function | |||||||||
| Biological species | ![]() ![]() | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.16 Å | |||||||||
Authors | Adams LJ / Fremont DH | |||||||||
| Funding support | United States, 2 items
| |||||||||
Citation | Journal: bioRxiv / Year: 2021 Title: A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope. Authors: Laura VanBlargan / Lucas Adams / Zhuoming Liu / Rita E Chen / Pavlo Gilchuk / Saravanan Raju / Brittany Smith / Haiyan Zhao / James Brett Case / Emma S Winkler / Bradley Whitener / Lindsay ...Authors: Laura VanBlargan / Lucas Adams / Zhuoming Liu / Rita E Chen / Pavlo Gilchuk / Saravanan Raju / Brittany Smith / Haiyan Zhao / James Brett Case / Emma S Winkler / Bradley Whitener / Lindsay Droit / Ismael Aziati / Pei-Yong Shi / Adrian Creanga / Amarendra Pegu / Scott Handley / David Wang / Adrianus Boon / James E Crowe / Sean P J Whelan / Daved Fremont / Michael Diamond Abstract: With the emergence of SARS-CoV-2 variants with increased transmissibility and potential resistance, antibodies and vaccines with broadly inhibitory activity are needed. Here we developed a panel of ...With the emergence of SARS-CoV-2 variants with increased transmissibility and potential resistance, antibodies and vaccines with broadly inhibitory activity are needed. Here we developed a panel of neutralizing anti-SARS-CoV-2 mAbs that bind the receptor binding domain of the spike protein at distinct epitopes and block virus attachment to cells and its receptor, human angiotensin converting enzyme-2 (hACE2). While several potently neutralizing mAbs protected K18-hACE2 transgenic mice against infection caused by historical SARS-CoV-2 strains, others induced escape variants in vivo and lost activity against emerging strains. We identified one mAb, SARS2-38, that potently neutralizes all SARS-CoV-2 variants of concern tested and protects mice against challenge by multiple SARS-CoV-2 strains. Structural analysis showed that SARS2-38 engages a conserved epitope proximal to the receptor binding motif. Thus, treatment with or induction of inhibitory antibodies that bind conserved spike epitopes may limit the loss of potency of therapies or vaccines against emerging SARS-CoV-2 variants. | |||||||||
| History |
|
-
Structure visualization
| Movie |
Movie viewer |
|---|---|
| Structure viewer | EM map: SurfView Molmil Jmol/JSmol |
| Supplemental images |
-
Downloads & links
-EMDB archive
| Map data | emd_23899.map.gz | 91.6 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-23899-v30.xml emd-23899.xml | 15.2 KB 15.2 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_23899_fsc.xml | 10.4 KB | Display | FSC data file |
| Images | emd_23899.png | 55.6 KB | ||
| Filedesc metadata | emd-23899.cif.gz | 6 KB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-23899 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-23899 | HTTPS FTP |
-Validation report
| Summary document | emd_23899_validation.pdf.gz | 491.2 KB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_23899_full_validation.pdf.gz | 490.8 KB | Display | |
| Data in XML | emd_23899_validation.xml.gz | 11.4 KB | Display | |
| Data in CIF | emd_23899_validation.cif.gz | 15.3 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-23899 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-23899 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 7mkmMC ![]() 7mklC C: citing same article ( M: atomic model generated by this map |
|---|---|
| Similar structure data |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_23899.map.gz / Format: CCP4 / Size: 103 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Focused map of SARS2-38 antibody Fv bound to SARS-CoV-2 receptor binding domain | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 1.16 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
CCP4 map header:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Supplemental data
-
Sample components
-Entire : SARS-CoV-2 spike bound by SARS2-38 antibody Fab
| Entire | Name: SARS-CoV-2 spike bound by SARS2-38 antibody Fab |
|---|---|
| Components |
|
-Supramolecule #1: SARS-CoV-2 spike bound by SARS2-38 antibody Fab
| Supramolecule | Name: SARS-CoV-2 spike bound by SARS2-38 antibody Fab / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#3 |
|---|---|
| Source (natural) | Organism: ![]() |
-Macromolecule #1: Spike protein S1
| Macromolecule | Name: Spike protein S1 / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 21.247758 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: TNLCPFGEVF NATRFASVYA WNRKRISNCV ADYSVLYNSA SFSTFKCYGV SPTKLNDLCF TNVYADSFVI RGDEVRQIAP GQTGKIADY NYKLPDDFTG CVIAWNSNNL DSKVGGNYNY LYRLFRKSNL KPFERDISTE IYQAGSTPCN GVEGFNCYFP L QSYGFQPT NGVGYQPYRV VVLSFELLHA UniProtKB: Spike glycoprotein |
-Macromolecule #2: SARS2-38 Fv heavy chain
| Macromolecule | Name: SARS2-38 Fv heavy chain / type: protein_or_peptide / ID: 2 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 12.490882 KDa |
| Sequence | String: QVQLKESGPG LVAPSQSLSI TCTVSGFSLT RYGVHWVRQP PGKGLEWLGV IWADGSTYYN SALMSRLSIS KDNSKSQVFL NMNSLQTDD TAKYYCARDG RGYDDYWGQG TTLT |
-Macromolecule #3: SARS2-38 Fv light chain
| Macromolecule | Name: SARS2-38 Fv light chain / type: protein_or_peptide / ID: 3 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 11.419787 KDa |
| Sequence | String: QIVLTQSPAI MSASPGEKVT MTCSASSTVS FIYWYQQKPG SSPRLLIYDT SNPASGVPVR FSGSGCGTSY YLTISRMEAE DAATYYCQQ WNTYPLTFGA GTKLEL |
-Macromolecule #4: 2-acetamido-2-deoxy-beta-D-glucopyranose
| Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 4 / Number of copies: 1 / Formula: NAG |
|---|---|
| Molecular weight | Theoretical: 221.208 Da |
| Chemical component information | ![]() ChemComp-NAG: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 7.4 |
|---|---|
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
| Microscope | FEI TITAN KRIOS |
|---|---|
| Image recording | Film or detector model: FEI FALCON IV (4k x 4k) / Average electron dose: 50.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi


Keywords

Authors
United States, 2 items
Citation
UCSF Chimera














Z (Sec.)
Y (Row.)
X (Col.)





















Homo sapiens (human)
Processing

